{
  "docId": "019dd923-622c-750b-8b9c-f6c472e7615d",
  "docSlug": "b2c1d9cb58c0",
  "documentTitle": "Valeant Pharmaceuticals International (VRX)",
  "authorId": "01_Pershing_Square",
  "authorName": null,
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "activist_investor",
  "sourceTypeLabel": "Activist investor",
  "presentationDate": "2015-10-30 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 13,
  "pageCount": 39,
  "prevPage": 12,
  "nextPage": 14,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a list format to build a case for regulatory scrutiny.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9c-f6c472e7615d/13",
  "deckHref": "/decks/019dd923-622c-750b-8b9c-f6c472e7615d",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9c-f6c472e7615d.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9c-f6c472e7615d#slide-13",
  "components": [
    {
      "bbox": {
        "h": 0.06,
        "w": 0.92,
        "x": 0.04,
        "y": 0.18
      },
      "kind": "callout",
      "text": "Regulatory Risk:",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b28a322c-ff59-41ff-9cac-ad1ae04f48c3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.88,
        "x": 0.08,
        "y": 0.63
      },
      "kind": "list",
      "text": "Effective October 29th, 2015, CVS Caremark, Express Scripts and UnitedHealth/Optum announced the termination of their relationship with Philidor, comprising the vast majority of the PBM market.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "050bfff7-a0a3-4b25-b00d-cbd47e112c89",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.92,
        "x": 0.04,
        "y": 0.48
      },
      "kind": "list",
      "text": "Philidor has been accused by a former contractor and debtor of illegal activity. Recent media reports indicate that Philidor may have engaged in fraudulent activity.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4c55f545-1f79-421a-9384-fe916422511e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.92,
        "x": 0.04,
        "y": 0.78
      },
      "kind": "list",
      "text": "Government inquiries into potential legal and regulatory violations in the pharmaceutical industry are pervasive and highly fact specific.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "86b876b9-2eee-4279-be8f-d00865f08332",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.92,
        "x": 0.04,
        "y": 0.26
      },
      "kind": "list",
      "text": "Valeant and Philidor operate in a highly regulated industry. It is legal for a manufacturer to own a pharmacy and several have/do. While Valeant consolidates Philidor for accounting purposes, Valeant has stated that they do not control Philidor.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "974a727e-4529-4728-a7d6-8bd698da30cc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.92,
        "x": 0.04,
        "y": 0.08
      },
      "kind": "title",
      "text": "Valeant’s Use of Specialty Pharmacies (cont’d)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fbd699f6-2052-4240-90e4-48eb8d40b138",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "fraud-exposure",
      "slug": null,
      "matchId": "419c4f15-b273-4f67-9467-38ae2fb04ab0",
      "evidence": "The slide explicitly details accusations of illegal activity and fraudulent behavior by Philidor.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}